High galectin-4 (HR = 0.65, 95% CI = 0.47–0.89, p = 0.008) and galectin-9 (HR = 0.46, 95% CI = 0.26–0.82, p = 0.009) expression were significantly correlated with better RFS in the patients with HCC. Here, LGALS9 is linked to hepatocellular carcinoma.